Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: A flow cytometric study

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 8, 2008, Pages 970-976

  Basak, P Y ^a,b   Adiloglu, A K ^b   Koc, I G ^b   Tas, T ^b   Akkaya, V B ^b  

^a Suleyman Demirel University ^*  (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Autoimmunity; Natural killer cells; T cells; Vitiligo

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; MEMBRANE ANTIGEN; NATURAL KILLER CELL RECEPTOR;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; EVALUATION; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOCYTE; NON SEGMENTAL VITILIGO; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VITILIGO;

ADULT; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; PHENOTYPE; RECEPTORS, NATURAL KILLER CELL; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; VITILIGO;

EID: 52249115853     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02681.x     Document Type: Article

References (26)

1. Ortonne J-P. Vitiligo and other disorders of hypopigmentation. In : Bolognia JL, Jorizzo JL, Rapini RP et al., eds. Dermatology. Mosby, Edinburg, 2003 : 947 973.
2. Ogg GS. Detection of antigen-specific cytotoxic T lymphocytes: significance for investigative dermatology. Clin Exp Dermatol 2000 25 : 312 316.
3. Palermo B, Campanelli R, Garbelli S et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers. The role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001 117 : 326 332.
4. Jie HB, Sarvetnick N. The role of NK cells and NK cell receptors in autoimmune disease. Autoimmunity 2004 37 : 147 153.
5. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev 2006 214 : 186 201.
6. Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev 2006 214 : 155 160.
7. Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladman DD. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 2007 69 : 106 108.
8. Halder RM, Walters CS, Johnson BA, Chakrabarti SG, Kenney JA Jr. Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study. J Am Acad Dermatol 1986 14 : 733 737.
9. Hann SK, Park YK, Chung KY, Kim HI, Im S, Won JH. Peripheral blood lymphocyte imbalance in Koreans with active vitiligo. Int J Dermatol 1993 32 : 286 289.
10. + T-cell subset and evidence for peripheral T-cell activation. Int J Dermatol 1992 31 : 321 326.
11. + of T-helper cells in non-segmental vitiligo. J Dermatol 2002 29 : 68 73.
12. Liao YH, Jee SH, Sheu BC et al. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. Br J Dermatol 2006 155 : 318 324.
13. Williams F, Meenagh A, Sleator C et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005 66 : 836 841.
14. Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol 2003 149 : 160 164.
15. +NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 2002 127 : 176 182.
16. Saruhan-Direskeneli G, Uyar FA, Cefle A et al. Expression of KIR and C-type lectin receptors in Behcet's disease. Rheumatology 2004 43 : 423 427.
17. Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease. Rheumatol Int 2004 24 : 212 216.
18. Ortonne JP, Alario A. T and B lymphocytes in vitiligo. Arch Dermatol Res 1978 261 : 147 151.
19. Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly AP, Alfred L. T cell profiles in vitiligo. J Am Acad Dermatol 1986 14 : 196 201.
20. Soubiran P, Benzaken S, Bellet C, Lacour JP, Ortonne JP. Vitiligo: peripheral T-cell subset imbalance as defined by monoclonal antibodies. Br J Dermatol 1985 113 : 124 127.
21. Alaibac M, Belloni Fortina A, Poletti A et al. In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseases. Arch Dermatol Res 2000 292 : 472 474.
22. Matsui T, Kurokawa M, Kobata T et al. Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol 1999 162 : 4328 4335.
23. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology 2006 117 : 1 10.
24. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998 161 : 571 577.
25. Rajagopalan S, Long EO. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005 201 : 1025 1029.
26. Moretta L, Moretta A. Killer immunoglobulin-like receptors. Curr Opin Immunol 2004 16 : 626 633.